Improving treatment for sickle cell disease
To improve care provided to patients with sickle cell disease, we need to establish clinically validated prognostic biomarkers. In her research, Marein Schimmel focuses on this need and on our current knowledge of the complex, multifactorial pathophysiology of the disease.
M. Schimmel: Sickle Cell Disease. Pathogenesis and Biomarkers.
Prof. D.P.M. Brandjes
Prof. M.H.J. van Oers
Dr B.J. Biemond
Dr S.S. Zeerleder
Oudezijds Voorburgwal 229 - 231 | 1012 EZ AmsterdamGo to detailpage
+31 (0)20 525 2362
This event is open to the public.